On 6-7 November 2017, a consultation was held at WHO Headquarters in Geneva with Member States, the PIP Advisory Group, GISRS, relevant international organizations, databases and initiatives, and all interested stakeholders. The objective of the consultation was to harvest views on the Scoping paper.
Evidence used in the development of the Scoping Paper
The Scoping paper was developed on the basis of the considerable evidence on seasonal influenza and GSD collected by WHO in the course of implementation of the PIP Framework. This evidence has been compiled in the documents below.